CVS Health Stock Prediction and Forecast [CVS]

AI-generated source summary

The analysis indicates that CVS Health has been ranked as a buy candidate since August 14, 2025, with a score of 1.09. The stock has shown a gain of 15% over 40 days, resulting in a 0.38% average daily gain. It's currently in a short-term upward trend, and the analysis suggests a potential 30% change in the next three months, estimating a return range between 26% and 34%. Over a 12-month period, a 34% change is projected, resulting in a price of between 79.94 and 104.28. The stock closed at 76.74 on the last trading day, down 0.247%, with a fluctuation of 1.48%. Trading volume decreased, the stock's current price 3.09% below its 52-week high, analyst ratings are generally positive, leading the report to deem its current price undervalued and a worthwhile buy.

AI-generated summary based on the source content.

Evidence and evaluation progress

1. Original source published

   10 Oct 2025, 03:44 UTC

   The analyst published the original source item.

2. First prediction resolved

   14 Oct 2025, 18:30 UTC

   The first evaluable outcome in this case reached a terminal result.

3. Case evaluation completed

   14 Oct 2025, 18:30 UTC

   All evaluable predictions in this case reached terminal outcomes.

4. Source recorded by Tahlil Plus

   18 May 2026, 20:23 UTC

   The public source was preserved as the evidence record for this case.

5. Market predictions extracted

   18 May 2026, 20:47 UTC

   1 eligible signal linked to this case.

6. Outcome tracking started

   02 Jul 2026, 02:10 UTC

   Tahlil Plus began monitoring the extracted predictions.